Search results for "Endocrine Glands"

showing 10 items of 103 documents

Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves' Orbitopathy.

2021

Opinionlcsh:RC648-665biologybusiness.industryEndocrinology Diabetes and MetabolismGraves’ orbitopathyReceptors Thyrotropinthyroid eye diseaselcsh:Diseases of the endocrine glands. Clinical endocrinologyThyrotropin receptorGraves OphthalmopathyEndocrinologyCancer researchbiology.proteinMedicineBiomarker (medicine)AnimalsHumansbiomarkerAntibodyfunctional thyrotropin receptor antibodiesbusinessBiomarkersstimulatory TSH receptor antibodiesAutoantibodiesFrontiers in endocrinology
researchProduct

Early development of human Merkel cells.

1992

Human fetal Merkel cells are now generally considered to be epidermal derivatives. Previous studies using antibodies against the simple epithelial cytokeratins (CKs), 8 and 18, have demonstrated the presence of these cells in the epidermis at as early as fetal week 10 to 12. Using antibodies against CK 20 whose expression within the skin is restricted to Merkel cells, we applied immunofluorescence and immunoperoxidase microscopy to analyze earlier embryonic and fetal human skin (wk 7 to 9). We were able to demonstrate the first Merkel cells at as early as fetal wk 8, i.e., at the same time as the epidermis starts to develop an intermediate, third layer, characterized by the expression of CK…

Pathologymedicine.medical_specialtyFluorescent Antibody TechniqueHuman skinGestational AgeDermatologyKeratin-20BiologyImmunofluorescenceBiochemistryImmunoenzyme TechniquesBasal (phylogenetics)FetusIntermediate Filament ProteinsEndocrine GlandsmedicineHumansMolecular BiologyFetusintegumentary systemImmunoperoxidasemedicine.diagnostic_testAntibodies MonoclonalEmbryonic stem cellmedicine.anatomical_structureEpidermal CellsEpidermisEpidermisMerkel cellHairExperimental dermatology
researchProduct

Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics

2017

Background: Anaplastic thyroid cancer (ATC) is a rare but extremely aggressive cancer of the thyroid, contributing up to 30-40% of thyroid cancer-specific mortality. We analyzed ATC characteristics and survival rates in Sicily to evaluate the possible influence of environmental factors. With this aim data regarding ATC incidences in urban/rural and industrial, iodine deficient and volcanic vs. control areas were compared in Sicily as well as ATC data from Sicily and USA. Methods: Using the Sicilian Register of Thyroid Cancer (SRTC) database incidence, age, gender, tumor size and histotype, extrathyroidal extension, stage and coexistence with pre-existing differentiated thyroid cancer (DTC) …

Pathologymedicine.medical_specialtyMultivariate analysisThyroid Cancer Registrythyroid cancer and volcanic environmentEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismlcsh:Diseases of the endocrine glands. Clinical endocrinologyPapillary thyroid cancer03 medical and health sciences0302 clinical medicineEndocrinologySurveillance Epidemiology and End Resultsthyroid cancerMedicineAnaplastic thyroid cancerThyroid cancerthyroid cancer epidemiologyOriginal ResearchUnivariate analysislcsh:RC648-665business.industryIncidence (epidemiology)Thyroidmedicine.diseaseDiabetes and Metabolismmedicine.anatomical_structure030220 oncology & carcinogenesisAnaplastic thyroid cancer; Thyroid cancer; Thyroid cancer and volcanic environment; Thyroid cancer epidemiology; Thyroid Cancer Registry; Endocrinology Diabetes and MetabolismbusinessDemographyanaplastic thyroid cancerFrontiers in Endocrinology
researchProduct

Medullary Thyroid Carcinoma With Exon 2 p.L56M RET Variant: Clinical Particular Features in Two Patients

2018

RET (REarranged during Transfection) proto-oncogene variants are essential for the development of familial and sporadic forms of medullary thyroid carcinoma (MTC). The most frequent variants are usually located in exons 10, 11, and 13 through 16 of the RET gene. We report two cases of apparently sporadic MTC associated with the variant in exon 2 of RET gene. Patient 1, a 62-year old man who had undergone adrenalectomy for a 5 cm pheochromocytoma, was screened for type 2 multiple endocrine neoplasia (MEN 2) which showed elevated basal and post-intravenous calcium gluconate calcitonin levels. A fine needle aspiration biopsy (FNAB) confirmed the suspicion of MTC. The patient underwent total th…

Pathologymedicine.medical_specialtyendocrine systemMedullary cavityendocrine system diseasesEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismCase ReportL56M; Medullary thyroid carcinoma; MEN2; Pheochromocytoma; RET; Endocrinology Diabetes and Metabolismlcsh:Diseases of the endocrine glands. Clinical endocrinologyThyroid carcinomaPheochromocytoma03 medical and health sciences0302 clinical medicineEndocrinologymedullary thyroid carcinomaBiopsymedicineMultiple endocrine neoplasialcsh:RC648-665medicine.diagnostic_testbusiness.industrySettore MED/13 - ENDOCRINOLOGIAHyperplasiamedicine.diseasepheochromocytomaDiabetes and MetabolismFine-needle aspirationMEN2Calcitonin030220 oncology & carcinogenesisbusinessRETL56MFrontiers in Endocrinology
researchProduct

The Impact of Diet and Physical Activity on Bone Health in Children and Adolescents.

2021

There is growing recognition of the role of diet and physical activity in modulating bone mineral density, bone mineral content, and remodeling, which in turn can impact bone health later in life. Adequate nutrient composition could influence bone health and help to maximize peak bone mass. Therefore, children’s nutrition may have lifelong consequences. Also, physical activity, adequate in volume or intensity, may have positive consequences on bone mineral content and density and may preserve bone loss in adulthood. Most of the literature that exists for children, about diet and physical activity on bone health, has been translated from studies conducted in adults. Thus, there are still man…

Peak bone massAdolescentEndocrinology Diabetes and MetabolismmacronutrientsPhysical activityPhysiologyParathyroid hormoneReviewGastric inhibitory peptideBone healthDiseases of the endocrine glands. Clinical endocrinologymacronutrients exercise bone mass gut peptides hormones children adolescentEndocrinologychildrenBone Densitygut peptidesMedicineHumansChildBone mineralbone massexercisehormonesbusiness.industryNutrientsRC648-665Gut hormonesDietBone DiseasesbusinessHormoneFrontiers in endocrinology
researchProduct

Glucocorticoids in Graves’ orbitopathy: mechanisms of action and clinical application

2020

Background:Graves’ orbitopathy (GO) is the most frequent extrathyroidal manifestation of the autoimmune Graves’ disease. GO significantly impacts quality of life and has a psycho-social morbidity. Inflammation and swelling of the orbital tissue often leads to proptosis, diplopia, and decrease of visual acuity. Due to the inflammatory background of the disease, glucocorticoids (GC) have been used as a first-line treatment for decades.Methods:PubMed and MeSH database were searched for original articles, clinical trials, reviews, and meta-analyses published between 1 January 2000 and 31 March 2020 and pertaining to both the mechanism of action and immunological effects of GC as well as to the …

Pediatricsmedicine.medical_specialtylcsh:RC648-665glucocorticoidsIntravenous methylprednisolonebusiness.industryGraves’ orbitopathyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismReviewthyroid eye diseaseDiseaselcsh:Diseases of the endocrine glands. Clinical endocrinologyintravenous methylprednisolonepharmacology immunologymechanisms of action03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Action (philosophy)030221 ophthalmology & optometrymedicinebusinessTherapeutic Advances in Endocrinology and Metabolism
researchProduct

Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus

2020

IntroductionCompare cost of the interstitial liquid glucose flash monitoring (FM) system (FreeStyle Libre 2) versus self-monitoring of blood glucose (SMBG) in adults with type 1 diabetes mellitus (T1DM) in Spain.Research design and methodsA model was developed to estimate, with the perspective of the Spanish health system, the annual costs associated with glucose monitoring and hypoglycemic events management in T1DM population, with multiple insulin daily doses (MDI). According to published evidence, rate of severe hypoglycemia (SHE) of 4.90 episodes per patient-year was applied. Reduction of SHE (58.6%) was modeled associated with FM use. Published rates of hospital care (20.2%) and subseq…

Research designAdultBlood Glucosemedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismPopulation030209 endocrinology & metabolismHypoglycemiaBedtimeDiseases of the endocrine glands. Clinical endocrinology03 medical and health sciences0302 clinical medicineDiabetes mellitusMedicine1867HumansHypoglycemic Agents030212 general & internal medicine1506Epidemiology/Health Services ResearcheducationType 1 diabeteseducation.field_of_studybusiness.industryBlood Glucose Self-Monitoringcost(s)nutritional and metabolic diseasesMonitoring systemmedicine.diseaseRC648-665glucose monitoringDiabetes Mellitus Type 1type 1SpainCohortEmergency medicineadult diabetes cost(s) glucose monitoring type 1adult diabetesbusinessBMJ Open Diabetes Research & Care
researchProduct

SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence

2021

Background. Over the last few years, the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1RA) has increased substantially in medical practice due to their documented benefits in cardiorenal and metabolic health. In this sense, and in addition to being used for glycemic control in diabetic patients, these drugs also have other favorable effects such as weight loss and lowering blood pressure, and more recently, they have been shown to have cardio and renoprotective effects with anti-inflammatory properties. Concerning the latter, the individual or associated use of these antihyperglycemic agents has been linked with a decrease in p…

SenescenceEndocrinology Diabetes and MetabolismAdipose tissueInflammationGlycemic ControlReview ArticleDiseaseBioinformaticsDiseases of the endocrine glands. Clinical endocrinologyGlucagon-Like Peptide-1 ReceptorProinflammatory cytokineEndocrinologySodium-glucose cotransporter 2 inhibitors (SGLT2i)Weight lossDiabetes mellitusmedicineHumansSodium-Glucose Transporter 2 InhibitorsCellular SenescenceGlycemicInflammationMetabolic SyndromeManagement of diabetesRonyonsDiabetisbusiness.industryRC648-665medicine.diseaseCor MalaltiesAdipose TissueantihyperglycemicPatients obesity and cardiorenal compromiseglycemic controlmedicine.symptombusinessGlucagon-like peptide 1 receptor agonists (GLP-1RA)
researchProduct

Validity of multiplex biomarker model of 6 genes for the differential diagnosis of thyroid nodules

2011

Abstract Background Currently the cytological examination of fine needle aspiration (FNA) biopsies is the standard technique for the pre-operative differential diagnosis of thyroid nodules. However, the results may be non-informative in ~20% of cases due to an inadequate sampling and the lack of highly specific, measurable cytological criteria, therefore ancillary biomarkers that could aid in these cases are clearly needed. The aim of our study was to evaluate the mRNA expression levels of 8 candidate marker genes as the diagnostic biomarkers for the discrimination of benign and malignant thyroid nodules and to find a combination of biomarkers with the highest diagnostic value. Materials an…

Thyroid nodulesPathologymedicine.medical_specialtylcsh:RC648-665medicine.diagnostic_testEndocrine and Autonomic Systemsbusiness.industryResearchEndocrinology Diabetes and Metabolismmedicine.diseaselcsh:Diseases of the endocrine glands. Clinical endocrinologyEndocrinologyFine-needle aspirationMedicineBiomarker (medicine)Sampling (medicine)MultiplexDifferential diagnosisbusinessGeneThyroid cancerThyroid Research
researchProduct

Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction

2013

The Visceral Adiposity Index (VAI) has recently proven to be an indicator of adipose distribution and function that indirectly expresses cardiometabolic risk. In addition, VAI has been proposed as a useful tool for early detection of a condition of cardiometabolic risk before it develops into an overt metabolic syndrome. The application of the VAI in particular populations of patients (women with polycystic ovary syndrome, patients with acromegaly, patients with NAFLD/NASH, patients with HCV hepatitis, patients with type 2 diabetes, and general population) has produced interesting results, which have led to the hypothesis that the VAI could be considered a marker of adipose tissue dysfuncti…

Visceral Adiposity Indexeducation.field_of_studyPathologymedicine.medical_specialtylcsh:RC648-665Endocrine and Autonomic Systemsbusiness.industryEndocrinology Diabetes and MetabolismPopulationAdipose tissueType 2 diabetesReview ArticleBioinformaticsmedicine.diseaselcsh:Diseases of the endocrine glands. Clinical endocrinologyPolycystic ovaryEndocrinologyHcv hepatitisAcromegalyMedicineMetabolic syndromebusinesseducationProspective cohort study
researchProduct